{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "@id": "http://www.apoplogic.com/#organization",
      "name": "Untitled Document",
      "url": "http://www.apoplogic.com/",
      "description": "Untitled Document Apoplogic Pharmaceuticals, Inc. 12635 East Montview Blvd., Suite 100 Aurora, CO 80045 http://www.apoplogic.com THE COMPANY ApopLogic is focused on the development and commercialization of B201-acetate (Breceptin) and AP-300 (Fasaret), a unique pluripotent synthetic peptide and a biologic respectively for the treatment of a wide range of solid tumors. Both products are targeted and biomarkers have been identified."
    },
    {
      "@type": "WebPage",
      "@id": "https://directory.websdocs.com/business/untitled-document-05003ede53#asg",
      "name": "Untitled Document ASG Directory Profile",
      "url": "https://directory.websdocs.com/business/untitled-document-05003ede53",
      "isPartOf": {
        "@id": "http://www.apoplogic.com/#organization"
      },
      "description": "Public business information published by the WebsDocs ASG Directory."
    }
  ]
}